Last 5 days! Next Monday starts the "Introduction to Hydraulic Modeling Using One-Dimensional HEC-RAS" course. This training course is designed to teach participants how to use the software for ...

These findings suggest that there is a narrow window or ‘sweet spot’ of oncogenic RAS signalling conducive to tumour formation; too much leads to abortive processes like growth arrest, and too little ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

The Higher Education Commission has launched PhD Country Directory Online System for the benefit of PhD scholars. It was inaugurated by Minister for Federal Education and Professional Training Rana ...

Ras-el-hanout is used in couscous, rice, meat and vegetable dishes ...

This handout is available for download in DOCX format and PDF format. In the most abstract sense, the function of an introductory paragraph is to move the reader from the world of daily life into the ...

The mission of Firehouse is to educate and inspire firefighters so that they can protect their communities and keep themselves safe. By providing news, lessons learned, tactical changes and focusing ...

🚀 Last 5 days to register! The "Hydrologic Simulation using HEC-HMS" course starts this Monday. HEC-HMS (Hydrologic Engineering Center's Hydrologic Modeling System) is a comprehensive software ...

With training camp report dates for all 32 clubs recently announced by the league, take a look at some of the important dates to know ahead of the 2026 season.

Daraxonrasib is poised to become the new standard of care for previously treated metastatic pancreatic cancer after detailed results from a Phase III clinical trial were released at the American ...